
Why White Blood Cells were used to study genetic past and future of Indians
But what sets it apart is its unique study approach apart from 135 million genetic variations.
Variants found in Indian genomes are not found anywhere around the world. (Photo: AFP)
While other countries have used saliva, umbilical cord, or skin cells to extract DNA, Indian scientists have used White Blood Cells (WBCs) for the same purpose.WBCs are cells produced in the bone marrow and circulated in the bloodstream. Also known as leukocytes, they help protect the body from infections and diseases.WHAT IS GENETIC INDIA PROJECT?Genome India Project is a scientific study performed by collecting genomes of 10,000 healthy individuals across communities.advertisementIt's a collaborative project of 20 institutions, which began in 2020 with the funding of the Department of Biotechnology, to create a comprehensive reference for Indian genomic diversity, establish a robust biobank for future research, enable open access to genomic data, develop affordable genetic tools for diagnostics, pave the way for precision medicine in India, and inspire the next generation of genomic innovators.Around 160 samples from non-tribal groups and 75 samples from tribal groups were collected from 83 population groups. The samples were collected from unrelated individuals to ensure accurate analysis of mutation.
Genome India Project is a scientific study performed by collecting genomes of 10,000 healthy individuals. (Photo: Getty)
While explaining how mutations can help in analysing diseases over time, Dr. Kumaraswamy Thangaraj, Principal Investigator of Genome India Project told IndiaToday.in, 'Certain mutations are disease-causing; some are distributed over the world, and some are Indian specific. We are looking at those kinds of mutations that will emerge only when we complete our analysis.'WHY HAVE THEY BEEN CHOSEN?The research conducted is unique because of the method of extracting genomes from the WBCs. They are chosen because of their stability, which helps in the accurate extraction of DNA.advertisementWhen asked about the role WBCs play in genome extraction, 'Any cell is sufficient,' said Dr K Thangaraj. He further added, 'Our idea is to do some biochemical analysis, like creating cell lines, storing blood as such, or isolating cell lines if you store serum separately. All this cannot be done with saliva, as we may not get enough strength for further use.''WBCs are the least contaminated ones, and they consequently offer one of the best sequencing options to derive good quality data at different levels,' said Dr Ravi Gupta, Vice President, Bioinformatics at MedGenome.MEDICAL IMPLICATIONS OF THE STUDYThe Department of Biotechnology has said that the variants found in Indian genomes are not found anywhere around the world.The report also mentions the custom of marrying within the local communities, clan, or tribe, known as endogamy, as the reason for increased mutation rates within the population.'Certain mutations are associated with disease,' said Dr Thangaraj. 'If we put all these mutations into an array, the diagnosis of any disease can be developed more cheaply.'
It's a collaborative project of 20 institutions. (Photo: Getty)
advertisementTreatment for the diseases will depend on the response from the individual. This will be checked after analysing the reaction of individuals to the treatment.'Certain individuals may respond positively to the treatment. For them, the new treatment may work. But in some, it may produce adverse effects, leading to the development of new drug–personalized medicines,' said Dr Thangaraj.The choice of using WBCs has led to an understanding of gene-disease relationships in the genetically diverse population of the country. However, scientists say a clear understanding of these genetic variations is important for developing targeted treatments and preventive strategies for the Indian population.'The Indian population is endogamous. We find population-specific mutations. Some are very rare, some are disease-causing,' said Dr Thangaraj. 'We are analysing 10,000 genomes in detail, and we will find the actual impact on this and write a bigger paper after 2-3 months.'Must Watch
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
13 minutes ago
- Business Standard
Rehab to ~25L cover: Find out how insured our athletes are against injuries
A career in sports could be financially rewarding. Medals and accompanying fame also add to the lure, nudging youngsters to take that leap. But there are pitfalls too, as injuries have cut short or reduced the career of many promising as well as established athletes worldwide. For many Indian athletes, especially those from modest backgrounds, a single accident can derail years of hard work and jeopardise their financial future. Medical bills pile up quickly, and the uncertainty of recovery can push families into debt. To provide athletes some cushion against such uncertainties, the government has rolled out several insurance and welfare initiatives. These government-backed schemes not just offer treatment, but provide financial cushioning to athletes, ensuring their focus remains on performance rather than the cost of recovery. Key national-level insurance schemes The Sports Authority of India (SAI) and the Ministry of Youth Affairs and Sports run multiple programmes that cover treatment and insurance for injuries: Pandit Deendayal Upadhyay National Welfare Programme: Provides up to ~10,00,000 for medical treatment to current and retired athletes or their families. This direct financial assistance plays a vital role in post-injury recovery. SAI Medical Insurance Schemes: Covers over 13,000 athletes, coaches and staff. Includes ~500,000 for general medical treatment and an additional ~25,00,000 for accidental death or severe injury. National Centre of Sports Sciences and Research (NCSSR): Offers specialised and subsidised treatment, injury management, and rehabilitation to athletes involved in national programmes, significantly reducing out-of-pocket healthcare costs. Central Athlete Injury Management System (CAIMS): Strengthens medical infrastructure, providing subsidised or free access to treatment facilities, indirectly relieving athletes from financial stress. State initiatives add more protection Several states are bolstering this ecosystem with their own athlete insurance policies: -Haryana offers a medical insurance cover of ~20,00,000 lakh for sportspersons. -Rajasthan's Mukhyamantri Sportsperson Beema Yojana provides ~10,00,000 cover and a ~20,000 monthly pension. What it means for athletes Reduced expenses: Access to government-funded treatment saves lakhs in private medical bills. Focused career building: With medical risks covered, athletes can train without financial anxiety. Caveats and the way forward However, there are gaps. These schemes mainly cover national-level athletes. Those at grassroots or in informal training systems remain uninsured. Awareness is another issue, athletes from rural areas often don't know such benefits exist.


Time of India
26 minutes ago
- Time of India
Hyderabad startup Stardour successfully test fires India's 1st Hydrogen-Oxygen propulsion engine
Representative Image HYDERABAD: Spacetech startup Stardour, a stealth-mode startup based out of Hyderabad, has on Monday said it has successfully test fired India's first hydrogen and oxygen propulsion engine that it developed in-house. The sustainable engine, which was tested at the Indian Institute of Science in Bengaluru, will power Stardour's flagship nextgen orbital transfer vehicle (OTV) called Lucas. The startup, which was set up in 2020 and is led by former ISRO scientist Rama Rao, expects the maiden launch of Lucas in the third quarter of 2027. Lucas is being designed to carry out scientific and commercial expeditions across low earth orbit (LEO), geostationary orbit (GEO) as well as the moon and Mars, among others. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad An OTV is nothing but a space tug that picks up payloads such as satellites from one orbit to another, from a launch vehicle's drop-off point to final orbit, and can also conduct other jobs like orbit changes, orbital refuelling and spacecraft repair, life extension services and debris removal. 'This successful test fire is not just a technical milestone; it's a signal to the world that India is ready to lead in the new era of sustainable and autonomous in-space logistics,' said Stardour director Rama Rao. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Find out: this is how you clean your yoga mat! Kingdom Of Men Undo According to IISc professor Pratikash Panda, the successful test-firing of Stardour's hydrogen-oxygen engine is a testament to the Indian startup's commitment to green propulsion technology and innovation in reusable spacecraft. The bootstrapped startup, founded by Sankarsh Chanda, is working on green propulsion, orbital mobility, and deep-space exploration.


Mint
43 minutes ago
- Mint
New IPO: NephroPlus files papers with Sebi for ₹353.4 crore IPO to expand Dialysis clinics
Nephrocare Health Services Limited, widely recognized under the brand name NephroPlus, has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to raise ₹ 353.4 crore through an initial public offering (IPO). The Hyderabad-based company plans to use the proceeds to expand its network of dialysis clinics across India and repay outstanding debt, with the balance allocated to general corporate purposes. The IPO will include a fresh issue of equity shares worth ₹ 353.4 crore and an offer-for-sale (OFS) of up to 1.27 crore equity shares by promoter and non-promoter shareholders. Among the OFS participants are Investcorp Private Equity Fund II, Healthcare Parent Limited, Edoras Investment Holdings Pte. Ltd., and 360 One Special Opportunities Fund. The company may also consider a pre-IPO placement of up to ₹ 70.6 crore, which would reduce the size of the fresh issue accordingly. Established in 2009, NephroPlus has emerged as Asia's largest dialysis services provider and the fifth-largest globally in terms of the number of treatments performed in FY25, according to a Frost & Sullivan report. As of now, the company operates 447 clinics across 269 cities in 21 Indian states and 4 Union Territories, serving over 33,000 patients annually. NephroPlus commands more than 50 percent revenue market share in India's organised dialysis services market. NephroPlus has also made a significant push into international markets. It currently operates 34 clinics in the Philippines, 5 in Nepal, 4 in Uzbekistan, and recently entered Saudi Arabia in a bid to tap the Middle East healthcare market. The company's promoters include Vikram Vuppala, BVP Trust (Bessemer Venture Partners), and Investcorp-affiliated entities. As per the DRHP, NephroPlus will allocate ₹ 129.1 crore from the fresh issue proceeds towards setting up new dialysis clinics in India, which aligns with its strategy to grow its domestic footprint. An additional ₹ 136 crore will be used to pre-pay or repay certain existing borrowings, enhancing the company's financial flexibility and improving its balance sheet. In FY25, the company reported ₹ 755.8 crore in revenue from operations and a profit after tax of ₹ 67 crore, reflecting robust growth amid increasing demand for kidney care services. With chronic kidney disease (CKD) rising as the third fastest-growing cause of death globally, and diabetes and hypertension being its primary drivers, NephroPlus is well-positioned to benefit from secular health trends. ICICI Securities, Ambit Private Limited, IIFL Capital Services, and Nomura Financial Advisory and Securities (India) are acting as Book Running Lead Managers (BRLMs) for the IPO. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.